Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

Clinical trial NCT02730299 · COMPLETED

Trial details

NCT number: NCT02730299
Sponsor: Gamida Cell ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hematological Malignancies Acute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)Chronic Myelogenous Leukemia (CML)Myelodysplastic Syndrome (MDS)Lymphoma Acute Leukemia

Start date: 2016-12-16
Primary completion: 2021-04-29
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.